Search

3i Group PLC

Закрыт

СекторИндексы

2,299 0.57

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

2298

Макс.

2324

Ключевые показатели

By Trading Economics

Доход

-1.3B

2B

Продажи

44M

236M

P/E

Средняя по отрасли

4.295

19.461

Прибыль на акцию

3.4

Дивидендная доходность

3.66

Рентабельность продаж

850.424

Сотрудники

223

EBITDA

-745M

2B

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+36.98% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

3.66%

3.47%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.3B

24B

Предыдущая цена открытия

2298.43

Предыдущая цена закрытия

2299

Новостные настроения

By Acuity

52%

48%

16 / 26 Рейтинг в Indices

3i Group PLC График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

14 мая 2026 г., 08:38 UTC

Отчет
Главные движущие силы рынка

3i Group Shares Plunge After Slowdown at Retailer Action

29 янв. 2026 г., 16:27 UTC

Главные движущие силы рынка

U.K. Private Equity Group 3i's Shares Surge on Strong Sales at Key Asset

13 нояб. 2025 г., 10:02 UTC

Отчет
Главные движущие силы рынка

3i Group Shares Tumble After Cautious Outlook

14 мая 2026 г., 09:08 UTC

Обсуждения рынка
Отчет

3i Group Suffers as Problems Mount at Retailer Action -- Market Talk

14 мая 2026 г., 07:04 UTC

Обсуждения рынка
Отчет

3i Group Buyback Might Be Eclipsed by Concerns on Key Holding Action -- Market Talk

14 мая 2026 г., 06:07 UTC

Отчет

3i Group: Private Equity Business Delivered Gross Investment Return of GBP5.30B in FY26

14 мая 2026 г., 06:06 UTC

Отчет

3i Group: Action Remained Significant Driver of Group's Performance in FY26

14 мая 2026 г., 06:05 UTC

Отчет

3i Group: FY2026 Total Return of GBP5.30B

14 мая 2026 г., 06:05 UTC

Отчет

3i Group Received GBP1.9B of Cash Proceeds From Portfolio in FY 2026

14 мая 2026 г., 06:04 UTC

Отчет

3i Group: Expect to See an Increase in Inflation Over Coming Months

14 мая 2026 г., 06:04 UTC

Отчет

3i Group: Market Environment Remains Complex Due to Middle East Situation

14 мая 2026 г., 06:03 UTC

Отчет

3i Group Declares Second Interim Dividend of 48p a Share

14 мая 2026 г., 06:02 UTC

Отчет

3i Group Plans Buyback of Up to GBP750M

14 мая 2026 г., 06:00 UTC

Отчет

3i FY Pretax Pft GBP5.29B

14 мая 2026 г., 06:00 UTC

Отчет

3i FY NAV/Shr GBP30.30

14 мая 2026 г., 06:00 UTC

Отчет

3i FY Net Pft GBP5.29B

14 мая 2026 г., 06:00 UTC

Отчет

3i FY EPS GBP5.386

26 мар. 2026 г., 14:12 UTC

Обсуждения рынка
Главные новостные события

Action, 3i Group's Flagship Holding, Suffers from Bleak Outlook for Discount Retailers -- Market Talk

29 янв. 2026 г., 14:18 UTC

Обсуждения рынка
Отчет

3i Group's Value Proposition Built on Discount Retailer -- Market Talk

29 янв. 2026 г., 08:47 UTC

Обсуждения рынка
Отчет

3i Faces Tough Conditions in France, Competition from Chinese E-Tailers -- Market Talk

29 янв. 2026 г., 07:06 UTC

Отчет

3i Group Gross Cash at Dec. 31 GBP995M

29 янв. 2026 г., 07:04 UTC

Отчет

3i Group: Action Gross Cash at Dec. 31 Was EUR807M

29 янв. 2026 г., 07:02 UTC

Отчет

3i Group: Action LFL Sales Up 6.1% in First Four Weeks of Jan

29 янв. 2026 г., 07:01 UTC

Отчет

3i Group: Action's Like-For-Like Sales Growth Was 4.9%

29 янв. 2026 г., 07:01 UTC

Отчет

3i Group: Action Net Sales, Operating Ebitda Rose 16% and 14%

29 янв. 2026 г., 07:00 UTC

Отчет

3i Group NAV Per Shr Rose to 3,017 Pence

13 нояб. 2025 г., 07:29 UTC

Отчет

3i Group: First Div Is Set at 50% of Total Div for FY2025

13 нояб. 2025 г., 07:29 UTC

Отчет

3i Group PLC Declares Dividend of 36.5p

13 нояб. 2025 г., 07:28 UTC

Отчет

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 нояб. 2025 г., 07:28 UTC

Отчет

3i Group Ended Period With Liquidity of GBP1.64B

3i Group PLC Прогноз

Целевая цена

By TipRanks

36.98% рост

Прогноз на 12 месяцев

Средняя 3,105.33 GBX  36.98%

Максимум 4,280 GBX

Минимум 1,850 GBX

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для 3i Group PLC на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

6 ratings

4

Покупка

0

Удержание

2

Продажа

Настроения

By Acuity

16 / 26Рейтинг в Индексы

Новостные настроения

Свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
help-icon Live chat